1997
DOI: 10.1006/bbrc.1997.7378
|View full text |Cite
|
Sign up to set email alerts
|

On the Regulation and Function of Human Polo-like Kinase 1 (PLK1): Effects of Overexpression on Cell Cycle Progression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

16
153
0
1

Year Published

2002
2002
2015
2015

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 188 publications
(173 citation statements)
references
References 39 publications
16
153
0
1
Order By: Relevance
“…Antisense oligodeoxynucleotides (ODNs) to Plk1 have also been shown to be effective for inhibition of its expression in tumor cell lines, leading to loss of cell viability and even demonstrating an antitumor activity in A549 xenografts (Elez et al, 2000). Results from transient expression of dominantnegative Plk1 differed from previous antibody microinjection experiments in that most of the mitotic HeLa cells were bipolar and cytokinesis seemed to be disrupted (Mundt et al, 1997). Expression of dominant-negative Plk1 via an adenoviral vector induces programmed cell death in most tumor cells but not in normal human mammary epithelial cells (Conn et al, 2000).…”
Section: Inhibition Of Plk1mentioning
confidence: 96%
“…Antisense oligodeoxynucleotides (ODNs) to Plk1 have also been shown to be effective for inhibition of its expression in tumor cell lines, leading to loss of cell viability and even demonstrating an antitumor activity in A549 xenografts (Elez et al, 2000). Results from transient expression of dominantnegative Plk1 differed from previous antibody microinjection experiments in that most of the mitotic HeLa cells were bipolar and cytokinesis seemed to be disrupted (Mundt et al, 1997). Expression of dominant-negative Plk1 via an adenoviral vector induces programmed cell death in most tumor cells but not in normal human mammary epithelial cells (Conn et al, 2000).…”
Section: Inhibition Of Plk1mentioning
confidence: 96%
“…Moreover, involvement of multiple Plk family members in mitotic exit would explain why phosphomutants of MKlp2 result in severe cytokinesis defects, while Plk1 depletion does not interfere with furrow ingression (van Vugt et al, 2004b). In addition, the fact that overexpression of both Plk1 and Plk3 results in multinucleation suggests cytokinesis is regulated by multiple Plk's (Mundt et al, 1997;Conn et al, 2000). Functional redundancy between Plk1 and Plk3 may also play a role in inheritance of cellular organelles during mitosis.…”
Section: Plk1 and Cytokinesismentioning
confidence: 99%
“…Conversely, we detected no Emi1 coprecipitating with Plk1's N-terminal kinase domain (Plk1-NT), indicating that the PBD is required for stable complex formation with Emi1. Despite the absence of the PBD, Plk1-NT reduced Emi1 levels in cell lysates as effectively as did full-length Plk1, presumably because overexpression obviates the need for stable association and because of the higher specific activity of Plk1's kinase domain in the absence of its C terminus (Mundt et al, 1997;Jang et al, 2002). We also found that the N terminus of Emi1, which contains its degron, was sufficient to associate with Plk1, whereas the region of Emi1 containing the F-box and zinc-binding motif was dispensable for this interaction ( Figure 4C).…”
Section: Physical Interaction Of Plk1 and Emi1mentioning
confidence: 99%